Global Cardiac Arrest Treatment Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028
"Global Cardiac Arrest Treatment Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global cardiac arrest treatment market report has been segmented on the basis of type, application, and region.
Global Cardiac Arrest Treatment Market: Overview
Cardiac arrest is a medical emergency condition in which the heart stops functioning and an unexpected loss of breathing and consciousness in patient. Cardiac arrest is activated by an electrical malfunction in the heart that may causes an irregular heartbeat. The symptoms are a sudden collapse, breathing problem, loss of consciousness, fatigue, fainting, blackouts, dizziness, chest pain, and vomiting.
Global Cardiac Arrest Treatment Market: Dynamics
Increasing incidences and prevalence of cardiovascular diseases across the globe is a key factor expected to drive the growth of the global cardiac arrest treatment market. According to the World Health Organization in 2016, estimated that around 17.9 Mn people pass away from cardiovascular diseases and which accounted for nearly 31% of all global deaths. In addition, rising healthcare expenditure, increasing number of elderly population, higher number of patients suffering from chronic diseases, various governments initiative about spreading awareness for the treatment of cardiac arrest are the factors expected to drive growth of the global market. However, the stringent regulatory authority rules for product approvals and product recalls are factors that could restraint growth of global cardiac arrest treatment market to a certain extent.
Global Cardiac Arrest Treatment Market: Segment Analysis
Among the treatment segments, the medical devices segment is expected to register a high market share in terms of revenue. This is due to, technological advancement in medical devices and high adoption rate of these devices among patients suffering from cardiovascular diseases. Among the sales channel segment, the hospital is expected to register the highest market share in terms of revenue during the forecast period.
Global Cardiac Arrest Treatment Market: Trends
Government of several countries is collaborating with prominent players in order to form various training programs and campaigns in order to spread awareness about the treatment. The aforementioned is a key trend observed in the target market currently.
Global Cardiac Arrest Treatment Market: Region Analysis
The market in North America is expected to dominate the global cardiac arrest treatment market, owing to increasing number of cases for sudden cardiac arrest (SCA) and growing geriatric population. According to the American Heart Association Research in 2018, Cardiovascular disease is regarded as the underlying cause of death accounting nearly 836,546 deaths in the US. The market in the Asia Pacific is expected to register fastest CAGR in during the next 10 years, due to developing medical infrastructure, rising awareness about the early prevention and treatment of diseases, and technological advancements. In addition, improvement in healthcare infrastructures and higher expenditures in the developing countries such as India and China is a factor expected to support growth of the cardiac arrest treatment in Asia Pacific. According to the Global Burden of Disease in 2015, It is estimated that nearly 60% of the world's coronary artery disease (CAD) patients are in South Asians countries.
Global Cardiac Arrest Treatment Market Segmentation
Segmentation by Treatment:
- Anti-arrhythmic Drugs
- Anticholinergic Drugs
- Others (fibrinolytic drugs, beta blockers, sodium bicarbonate, crystalloids, colloids, etc.)
- Medical Devices
- Cardiac Resynchronization Therapy (CRT)
Segmentation by sales channel:
- Independent Pharmacies
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- Amgen, Inc.
- Pfizer, Inc.
- Johnson & Johnson
- Novartis AG
- Bristol-Myers Squibb Company
- Abbott Laboratories
- Bayer AG
- Koninklijke Philips N.V.
- GE Healthcare
- Physio-Control, Inc. (Stryker)
- Boston Scientific Corporation
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!